We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.85%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
VAM
51
Visium Asset Management
New York
$254M -$196M -875,394 -45%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$250M +$75.2M +336,240 +48%
CCI
53
Columbus Circle Investors
$244M -$12.2M -54,292 -5%
U
54
UBS
Switzerland
$241M +$18.2M +81,242 +9%
HCM
55
Hoplite Capital Management
New York
$231M
American Century Companies
56
American Century Companies
Missouri
$226M -$60M -268,035 -22%
VOYA Investment Management
57
VOYA Investment Management
Georgia
$217M -$8.46M -37,822 -4%
UBS AM
58
UBS AM
Illinois
$215M +$69.7M +311,579 +54%
Wells Fargo
59
Wells Fargo
California
$213M +$103M +461,201 +109%
Millennium Management
60
Millennium Management
New York
$209M +$132M +588,534 +211%
SO
61
STRS Ohio
Ohio
$209M -$8.06M -36,036 -4%
EPCM
62
Eton Park Capital Management
New York
$207M +$37.4M +167,000 +24%
Lord, Abbett & Co
63
Lord, Abbett & Co
New Jersey
$187M -$132M -587,770 -43%
CS
64
Credit Suisse
Switzerland
$185M +$67M +299,437 +64%
California Public Employees Retirement System
65
California Public Employees Retirement System
California
$185M +$53.1M +237,113 +45%
First Eagle Investment Management
66
First Eagle Investment Management
New York
$179M +$7.57M +33,842 +5%
Ameriprise
67
Ameriprise
Minnesota
$174M -$3.49M -15,610 -2%
Mitsubishi UFJ Trust & Banking
68
Mitsubishi UFJ Trust & Banking
Japan
$174M +$80.3M +358,796 +99%
Barclays
69
Barclays
United Kingdom
$173M +$129M +577,836 +410%
OA
70
Omega Advisors
New York
$170M +$158M +706,472 New
CCM
71
Conatus Capital Management
Connecticut
$169M +$36M +160,782 +30%
PHS
72
PFM Health Sciences
California
$166M -$20M -89,525 -11%
RFC
73
Russell Frank Company
Washington
$162M +$52.9M +236,444 +54%
Allianz Asset Management
74
Allianz Asset Management
Germany
$160M +$14.7M +65,892 +11%
AII
75
AGF Investments Inc
Ontario, Canada
$159M +$14.1M +62,839 +11%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.